poisar

Stock

Intelligent Bio Solutions Inc. INBS

$2.77-7.67%

Overview

INBS market data

Price History

INBS price chart

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$20.04
Diluted earnings per share over the trailing twelve months.
Beta
4.35
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-296.8%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$1.52 – $24.90
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $4.7M · P/B 4.20 · P/S 1.21.

Company News

8 captured
8-K filing — INTELLIGENT BIO SOLUTIONS INC. (INBS)SEC EDGAR · Aug 11, 2026, 9:29 PM
Intelligent Bio Solutions Says It Completed 135-Participant Method Comparison Study, Concluding All Clinical Data Collection For FDA 510(k) Submission Targeted In H2 2026Benzinga · Aug 11, 2026, 12:32 PM
Intelligent Bio Solutions Completes Usability Study For Intelligent Fingerprinting Drug Screening System To Detect Opiate CodeineBenzinga · Aug 5, 2026, 12:37 PM
Intelligent Bio Solutions Announces Completion Of Interference Study Supporting FDA 510(k) Submission For Codeine Detection, Remains On Track To Submit In H2 2026Benzinga · Aug 3, 2026, 12:32 PM
Intelligent Bio Solutions Resolves All Cybersecurity, Software-Related Review Items For Its Upcoming FDA SubmissionBenzinga · Jul 23, 2026, 12:36 PM
Intelligent Bio Solutions Completes Precision Testing For Its Intelligent Fingerprinting Drug Screening System To Detect Opiate CodeineBenzinga · Jul 21, 2026, 12:32 PM
Intelligent Bio Solutions Starts Interference Study To Support FDA Submission For U.S. Market Clearance Of Its Intelligent Fingerprinting Drug Screening System For Codeine DetectionBenzinga · Jun 16, 2026, 12:40 PM
Intelligent Bio Solutions Initiates Multi-Site Method Comparison Study To Support FDA 510(k) Submission For US Market Clearance Of Intelligent Fingerprinting Drug Screening System For Opiate CodeineBenzinga · Jun 2, 2026, 12:36 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock